Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

This grant funds scientific research that uses data from expanded access to investigational drugs or biologics for ALS. It supports studies on intermediate-size patient populations with ALS who cannot enroll in ongoing clinical trials for prevention, diagnosis, mitigation, treatment, or cure.